Efficacy of Topical Cyclosporine A for Treatment and Prevention of Graft Rejection in Corneal Grafts With Previous Rejection Episodes

NCT01028443 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Endothelial Graft Rejection

Interventions

DRUG: Sandimmune
DRUG: Artelose

Sponsor

Shahid Beheshti University of Medical Sciences